Experimental compound extends life in ALS mouse model
UT Southwestern Medical CenterUT Southwestern Medical Center researchers have identified an experimental molecular compound that improved survival among cellular models and mouse models of amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease.